Farydak (panobinostat) is a medication that's taken by mouth for the treatment of multiple myeloma (a type of bone marrow cancer). It was initially approved to be a part of a treatment that also included Velcade (bortezomib) and dexamethasone (Taperdex). It was only to be used by certain people for whom previous chemotherapy treatments didn't work well. Farydak (panobinostat) has been discontinued by the manufacturer and is no longer available in the United States.
Multiple myeloma
Multiple myeloma, with dexamethasone or after stem cell transplant
Myelodysplastic syndromes (deletion 5q)
Mantle cell lymphoma, relapsed or refractory after 2 prior therapies, including Velcade (bortezomib)
Follicular lymphoma, previously treated
Marginal zone lymphoma, previously treated
Lymphomas
Multiple myeloma
Leukemias
Mycosis fungoides (a type of lymphoma affecting the skin)
Ovarian cancer
Breast cancer
Certain childhood cancers (e.g., neuroblastoma, retinoblastoma)
Nephrotic syndrome (kidney problem) in children - pill form only
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.